Xero's recent decline might have reflected excessive negativity—its earnings are outperforming the downward trend

Xero's Share Price Plunge: A Shift in Market Sentiment

Xero's stock has experienced a sharp downturn, dropping 35% in 2026 and an even steeper 53% over the last half-year. Once a standout among growth stocks, Xero has seen its value fall nearly 79% from its peak. This isn't a simple dip—it's a significant recalibration of investor expectations, with the market now anticipating a lasting slowdown after years of rapid expansion.

The main debate centers on whether this dramatic sell-off is warranted or if it reflects excessive pessimism. Despite the share price collapse, Xero's financial performance has improved: over the past year, earnings per share rose by 21%. This disconnect between market sentiment and company fundamentals highlights a growing gap. While investors brace for stagnation, Xero's numbers show continued strength.

This tension is at the heart of the current narrative. The 35% drop in 2026 was triggered by several factors: a disappointing FY25 report, an expensive acquisition, and a broader tech sector downturn. Yet, with earnings rising, the sell-off seems to be a classic case of "sell the news," where lofty expectations were not just missed but reversed. The key question is whether the market has overreacted, leaving Xero undervalued compared to its actual financial trajectory.

The Expectation Gap: Forecast Misses and a Cautious Outlook

Xero's decline was driven by a series of events that widened the gap between market expectations and actual results. The most immediate catalyst was the Q1 2025 earnings release. Despite a 26.10% revenue beat, shares fell 11.06% because core profits missed by a wide margin. EPS came in at $0.83, falling short of estimates by 30.25%. This scenario, where revenue outperformed but profits lagged, signaled underlying cost challenges that growth alone couldn't overcome.

Mean Reversion Long-Only Strategy Overview

• Entry: Buy when XRO.AX closes below its 20-day simple moving average by more than two standard deviations.
• Exit: Sell when the price closes above the 20-day SMA, after 10 trading days, or if a 10% profit or 5% loss threshold is reached.
• Risk Controls: Take-profit at 10%, stop-loss at 5%, maximum hold of 10 days.

Backtest Results

• Strategy Return: -14.8%
• Annualized Return: -5.2%
• Maximum Drawdown: 35.23%
• Profit-Loss Ratio: 0.94
• Total Trades: 12
• Winning Trades: 5
• Losing Trades: 7
• Win Rate: 41.67%
• Average Hold Days: 4.58
• Max Consecutive Losses: 4
• Average Win Return: 7.32%
• Average Loss Return: 6.99%
• Largest Single Win: 14.78%
• Largest Single Loss: 10.19%

The disappointing FY25 results were quickly followed by news that Xero would acquire Melio, a US payments company, for US$2.5 billion. This sparked a wave of selling, as investors worried about the deal's size and its effect on cash flow. The acquisition, while potentially strategic, was viewed as an expensive distraction at a time when Xero was struggling to hit profit targets. It shifted the focus from organic growth to capital-intensive expansion, raising concerns about management's priorities and the company's ability to sustain high growth without sacrificing returns.

Market skepticism intensified later in the year. When Xero released its FY26 interim results in November, the response was negative despite a 20% increase in operating revenue and a 21% rise in EBITDA. The stock continued to fall, indicating that investors were already anticipating a more cautious outlook for the full year. The interim results, though solid, likely failed to deliver the guidance or margin improvements needed to restore confidence after the Melio acquisition shock. This November sell-off solidified the lower expectations for FY26, setting the stage for ongoing weakness.

Valuation and Future Prospects: Is Recovery Possible?

While expectations have been reset, Xero's current valuation may offer some downside protection. Analyst price targets remain above current levels, with the median estimate at $144.80, suggesting considerable upside if the company can deliver. The wide gap between market price and analyst consensus implies that investors are bracing for further disappointment, but also leaves room for positive surprises if execution improves.

Financial models still point to a promising long-term outlook. According to TIKR, Xero could see over 38% growth in shareholder value by 2030. This projection is based on Xero's strengths: a large market with low cloud adoption, a sticky platform for small businesses, and proven margin expansion. Recent half-year results show continued scaling, with revenue up 22% and operating income more than doubling. Achieving this growth depends on successfully integrating Melio and reigniting subscriber growth, which was a key driver in the past.

However, the main risk is another guidance reset. Xero's long-term plans assume successful expansion, but recent profit misses and the costly acquisition have created uncertainty. If subscriber growth slows or profitability falls short of revised targets, the stock could face renewed selling. The expectation gap has widened, and the market is quick to penalize any slip. For now, valuation offers a buffer, but that depends on management executing its next phase effectively.

Key Catalysts and What Investors Should Monitor

Xero's future trajectory depends on several critical events. The upcoming full-year FY26 earnings report will be pivotal, offering the first comprehensive look at performance post-Melio acquisition. Investors will focus on whether Xero meets its growth targets and if promised cost synergies and revenue gains from Melio are materializing. Any shortfall relative to the new, lower expectations could prompt further re-pricing.

Another major uncertainty is the integration of Melio. The June sell-off was driven by concerns about the deal's size and its impact on cash flow. Investors will look for clear evidence that integration is on track and that Melio is contributing to subscriber growth and cash flow as anticipated. Xero's guidance for FY26 already factors in higher operating expenses as a percentage of revenue, so additional cost overruns or delays in synergy realization would be a significant warning sign.

Finally, keep an eye on any updates to Xero's ambitious goal of doubling group revenue by FY28. This target was central to the company's growth story before the acquisition. If management signals that this goal is threatened by acquisition challenges or broader market headwinds, it would mark a fundamental shift. Conversely, reaffirming this target with clear milestones could restore confidence and suggest the worst is over. For now, Xero's low valuation provides some safety, but that depends entirely on upcoming catalysts meeting the market's more cautious expectations.